Stoke Therapeutics Inc sell BiotechBee
Start price
17.03.24
/
60%
€5.80
Target price
31.01.26
€3.00
Performance (%)
60.34%
End price
25.03.24
€9.30
Summary
This prediction ended on 25.03.24 with a price of €9.30. The SELL prediction by BiotechBee for Stoke Therapeutics Inc was trending in the completely wrong direction and closed with a performance of 60.34%. BiotechBee has a follow-up prediction for Stoke Therapeutics Inc, but this time predicts that Stoke Therapeutics Inc is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 15.315% | 15.315% |
| iShares Core DAX® | -0.383% | 5.404% |
| iShares Nasdaq 100 | 1.248% | 6.732% |
| iShares Nikkei 225® | 0.525% | 1.840% |
| iShares S&P 500 | 0.640% | 4.710% |
According to BiotechBee what are the pros and cons of Stoke Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Stoke Therapeutics Inc diskutieren
In the thread Trading Stoke Therapeutics Inc
Current prediction by BiotechBee for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€9.30
25.03.24
25.03.24
€23.00
30.06.26
30.06.26
36.56%
17.05.24
17.05.24
Could be very worthwhile Investment >20% year
